Page last updated: 2024-08-24

fluorodeoxyglucose f18 and memantine

fluorodeoxyglucose f18 has been researched along with memantine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berghold, A; Enzinger, C; Fazekas, F; Kolassa, H; Ofner, P; Pendl, B; Ropele, S; Schmidt, H; Schmidt, R; Windisch, M1
Hertel, A; Hofmann, E; Kiessling, B; Krasz, D; Nikisch, G; Wagner, T; Wiedemann, G1
Black, SE; Chow, TW; Fam, D; Graff-Guerrero, A; Houle, S; Masellis, M; Pollock, BG; Tang-Wai, DF; Verhoeff, NP; Wilson, AA1
Chen, K; Huang, Q; Li, C; Li, G; Li, X; Lin, Z; Reiman, EM; Wang, T; Xiao, S1
Dedeurwaerdere, S; Deleye, S; Staelens, S; Stroobants, S; Verhaeghe, J; wyffels, L1
Langlois, X; Schmidt, M; Staelens, S; Stroobants, S; Wyckhuys, T; Wyffels, L1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and memantine

ArticleYear
Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.
    European journal of medical research, 2008, Dec-03, Volume: 13, Issue:12

    Topics: Age of Onset; Alzheimer Disease; Cholinesterase Inhibitors; Codon; Donepezil; Electrophysiology; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Indans; Male; Memantine; Middle Aged; Mutation, Missense; Neuropsychological Tests; Pedigree; Piperidines; Presenilin-2; Radiography; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins; Time Factors; Treatment Outcome

2008

Trials

2 trial(s) available for fluorodeoxyglucose f18 and memantine

ArticleYear
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
    Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:12

    Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memantine; Middle Aged; Pilot Projects; Placebos

2008
Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:5

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Chi-Square Distribution; China; Cognition; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Memantine; Middle Aged; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Time Factors; Treatment Outcome

2013

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and memantine

ArticleYear
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study.
    International journal of geriatric psychiatry, 2013, Volume: 28, Issue:3

    Topics: Antiparkinson Agents; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Memantine; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors

2013
Towards a reproducible protocol for repetitive and semi-quantitative rat brain imaging with (18) F-FDG: exemplified in a memantine pharmacological challenge.
    NeuroImage, 2014, Aug-01, Volume: 96

    Topics: Animals; Brain; Computer Simulation; Fasting; Fluorodeoxyglucose F18; Image Enhancement; Male; Memantine; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity

2014
The [18F]FDG μPET readout of a brain activation model to evaluate the metabotropic glutamate receptor 2 positive allosteric modulator JNJ-42153605.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 350, Issue:2

    Topics: Allosteric Regulation; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Ketamine; Male; Memantine; Pyridines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Triazines

2014